112 related articles for article (PubMed ID: 17341144)
1. AL-34662: a potent, selective, and efficacious ocular hypotensive serotonin-2 receptor agonist.
Sharif NA; McLaughlin MA; Kelly CR
J Ocul Pharmacol Ther; 2007 Feb; 23(1):1-13. PubMed ID: 17341144
[TBL] [Abstract][Full Text] [Related]
2. Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.
Sharif NA; McLaughlin MA; Kelly CR; Katoli P; Drace C; Husain S; Crosson C; Toris C; Zhan GL; Camras C
Exp Eye Res; 2009 Mar; 88(3):386-97. PubMed ID: 18992242
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacology, ocular tolerability and ocular hypotensive efficacy of a novel non-peptide bradykinin mimetic small molecule.
Sharif NA; Li L; Katoli P; Xu S; Veltman J; Li B; Scott D; Wax M; Gallar J; Acosta C; Belmonte C
Exp Eye Res; 2014 Nov; 128():170-80. PubMed ID: 25307520
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
[TBL] [Abstract][Full Text] [Related]
5. Serotonin-2 (5-HT2) receptor-mediated signal transduction in human ciliary muscle cells: role in ocular hypotension.
Sharif NA; Kelly CR; Crider JY; Davis TL
J Ocul Pharmacol Ther; 2006 Dec; 22(6):389-401. PubMed ID: 17238805
[TBL] [Abstract][Full Text] [Related]
6. Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction.
Sharif NA; Kelly CR; McLaughlin M
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4001-10. PubMed ID: 16936116
[TBL] [Abstract][Full Text] [Related]
7. Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action.
Sharif NA
Curr Drug Targets; 2010 Aug; 11(8):978-93. PubMed ID: 20426763
[TBL] [Abstract][Full Text] [Related]
8. FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys.
Sharif NA; Katoli P; Scott D; Li L; Kelly C; Xu S; Husain S; Toris C; Crosson C
Drug Dev Res; 2014 Jun; 75(4):211-23. PubMed ID: 24796320
[TBL] [Abstract][Full Text] [Related]
9. Human non-pigmented ciliary epithelium bradykinin B2-receptors: receptor localization, pharmacological characterization of intracellular Ca(2+) mobilization, and prostaglandin secretion.
Sharif NA; Wang Y; Katoli P; Xu S; Kelly CR; Li L
Curr Eye Res; 2014 Apr; 39(4):378-89. PubMed ID: 24624903
[TBL] [Abstract][Full Text] [Related]
10. The effect of unoprostone isopropyl on Ca2+ release-activated Ca2+ currents in cultured monkey trabecular meshwork cells and ciliary muscle cells.
Shimura M; Yasuda K; Nakzawa T; Kashiwagi K
J Ocul Pharmacol Ther; 2006 Aug; 22(4):219-26. PubMed ID: 16910861
[TBL] [Abstract][Full Text] [Related]
11. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
Kelly CR; Sharif NA
J Pharmacol Exp Ther; 2006 Jun; 317(3):1254-61. PubMed ID: 16517693
[TBL] [Abstract][Full Text] [Related]
13. Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
Sharif NA; Xu SX; Crider JY; McLaughlin M; Davis TL
J Ocul Pharmacol Ther; 2001 Aug; 17(4):305-17. PubMed ID: 11572462
[TBL] [Abstract][Full Text] [Related]
14. A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.
May JA; Chen HH; Rusinko A; Lynch VM; Sharif NA; McLaughlin MA
J Med Chem; 2003 Sep; 46(19):4188-95. PubMed ID: 12954071
[TBL] [Abstract][Full Text] [Related]
15. Trabecular meshwork bradykinin receptors: mRNA levels, immunohistochemical visualization, signaling processes pharmacology, and linkage to IOP reduction.
Sharif NA; Katoli P; Kelly CR; Li L; Xu S; Wang Y; Klekar L; Earnest D; Yacoub S; Hamilton G; Jacobson N; Shepard AR; Ellis D
J Ocul Pharmacol Ther; 2014 Feb; 30(1):21-34. PubMed ID: 24236827
[TBL] [Abstract][Full Text] [Related]
16. Protein expression, biochemical pharmacology of signal transduction, and relation to intraocular pressure modulation by bradykinin B₂ receptors in ciliary muscle.
Sharif NA; Xu S; Li L; Katoli P; Kelly CR; Wang Y; Cao S; Patil R; Husain S; Klekar L; Scott D
Mol Vis; 2013; 19():1356-70. PubMed ID: 23805043
[TBL] [Abstract][Full Text] [Related]
17. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503.
Rosenzweig-Lipson S; Zhang J; Mazandarani H; Harrison BL; Sabb A; Sabalski J; Stack G; Welmaker G; Barrett JE; Dunlop J
Brain Res; 2006 Feb; 1073-1074():240-51. PubMed ID: 16430874
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys.
May JA; McLaughlin MA; Sharif NA; Hellberg MR; Dean TR
J Pharmacol Exp Ther; 2003 Jul; 306(1):301-9. PubMed ID: 12676887
[TBL] [Abstract][Full Text] [Related]
19. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
[TBL] [Abstract][Full Text] [Related]
20. A Novel Selective Soluble Guanylate Cyclase Activator, MGV354, Lowers Intraocular Pressure in Preclinical Models, Following Topical Ocular Dosing.
Prasanna G; Ferrara L; Adams C; Ehara T; Li B; Yang L; Xiang C; Ng CTH; Kim S; Towler C; Topley T; McAllister C; Ghosh M; Newton R; Stacy R; Rice DS; Mogi M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1704-1716. PubMed ID: 29610853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
